Cookie banner

This site uses cookies. Select "Block all non-essential cookies" to only allow cookies necessary to display content and enable core site features. Select "Accept all cookies" to also personalize your experience on the site with ads and partner content tailored to your interests, and to allow us to measure the effectiveness of our service.

To learn more, review our Cookie Policy, Privacy Notice and Terms of Use.

clock menu more-arrow no yes mobile

Filed under:

Kinerase Will Launch a New Mass Market Skincare Line This February

New, 1 comment

Racked is no longer publishing. Thank you to everyone who read our work over the years. The archives will remain available here; for new stories, head over to, where our staff is covering consumer culture for The Goods by Vox. You can also see what we’re up to by signing up here.

Results-oriented skincare brand Kinerase will launch a mass market offshoot called Dr. LeWinn by Kinerase at Walmart and Walgreens stores next month. The new line will comprise 10 products priced between $10 and $35—compared to $100+ for Kinerase's main line.

According to WWD:

Dr. LeWinn by Kinerase will “bring to mass not only a dermatology perspective but a plastic-surgery perspective,” said Jen Smoot, marketing director for Aliso Viejo, Calif.-based Valeant’s U.S. cosmeceuticals division. She added it will have “the latest ingredients that you find in department stores but don’t find outside of department stores until three of four years later.” Still, she noted that Dr. LeWinn by Kinerase products would have “only two to three cosmeceutical-grade ingredients” versus 10 to 12 in a Kinerase prestige product.
· Kinerase’s Mass Market Offshoot [WWD]